Phase III Study of a Topical Gel Formulation for Treatment and Prevention of Raynaud's Phenomenon

The Center for Rheumatology, Albany

Georgetown University Medical Center, Washington D.C.

Johns Hopkins Bayview Medical Center, Baltimore

Duke University, Durham

Standford Medical School, Stanford

University of Connecticut, Farmington

Lund University Hospital, Lund

Royal National Hospital for Rheumatic Diseases, Bath

Ninewells Hospital and Medical School, Dundee

University of Leeds, Leeds

Royal Free Hospital, London

Hope Hospital, Salford